Clinical trial NCT02044458: Foley Catheter for Induction of Labor
Official title: A Randomized Control Trial of Foley Catheter Placement for Induction of Labor: Stylette Versus no Stylette
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Foley Catheterization
Induction of Labor
5 French Stylette
Keywords: Foley Catheterization
Induction of Labor
5 French Stylette
Lead sponsor: Wake Forest University Health Sciences
Sponsor class: OTHER
First posted: 2014-01-24
Enrollment: 134
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Study Design:

Allocation: 2 arms Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Detailed Description

The utilization of a Foley catheter for induction of labor is well established. There are two techniques readily used for placing a Foley catheter. The most common method is under direct visualization of the cervix during a sterile speculum examination and the other method is to place a catheter during a digital cervical examination.

Studies have reported the use of a rigid stylette (a thin wire inserted into a catheter to maintain rigidity) to guide the insertion of the Foley catheter decreases failure rate. The Foley catheter plus rigid stylette technique seems to be an efficient and safe method for labor induction. However, to our knowledge there is no study that assesses the difference between the standard digital placement of a Foley catheter versus the digital placement of a Foley catheter with stylette.

Detailed description: Outcomes:

Primary Outcome Measures:

• The duration of insertion between the Foley catheter groups with and without a stylette.

Secondary Outcome Measures:

• Pain assessed by visual analogue scale (VAS), in women randomly allocated to rigid stylette or no rigid stylette placement of a Foley catheter for induction of labor.

Tertiary Outcome Measure:

• Compare the failure rate of the placement of a Foley catheter for induction of labor in women randomly allocated to rigid stylette or no rigid stylette

Design and Methods:

The decision to proceed with induction of labor with Foley catheter will be made by the attending obstetrician caring for the patient. Women requiring induction of labor will be consented to be in the study when the need for induction is confirmed. After obtaining informed consent, the nurse involved in the patient care will be notified of the patient's participation in the study. Random assignment to either a Foley bulb with 5 French stylette versus without will be achieved by the resident physician selecting the next sealed, opaque envelopes containing the assignment information. The envelopes only show the randomization number on the outside. Envelopes will be kept on the Labor and Delivery ward. It will be impossible for the performing physician or the patient to be blinded to the condition of the study due to the instruments needed for the different techniques. The performing physician will be decided prior to the envelop selection and will be the same resident physician who obtained the patient's Bishop Score. A 22 French Foley catheter will be used in both groups of the study. A 5 French stylette (also known as a rigid catheter guide or urethral manipulator used in the TVT procedure) will be used in the group assigned to the stylette.

Pre-induction cervical examination and assessment of Bishop score to be done by an OB/GYN resident physician (PGY 2-4) on the labor and delivery ward. Insertion technique for the Foley bulb with or without the 5 French stylette will be started in the same way. The patient will be placed in the dorsal lithotomy position. The labor bed will be disassembled in the normal fashion as is done for laboring patients with the foot of the bed removed. The patient's feet will then be placed in foot rests. The OB/GYN resident (PGY 2-4) will then perform a vaginal examination to identify the internal os. The Foley catheter, with or without stylette, will then be guided over the examiner's hand and into the endocervix. When the Foley balloon is past the internal os, the balloon will be inflated with 50cc normal saline. The Foley catheter will be placed on gentle traction and taped to the right medial thigh of the patient. Gentle traction will be reapplied every 30-60 minutes with reapplication of the tape to the right medial thigh by the Registered Nurse. This will be continued until expulsion of the Foley balloon or at a maximum duration of 12-24 hours. After expulsion of the Foley balloon, induction of labor will be further carried out with oxytocin infusion and/or with artificial rupture of membranes.. If the Foley catheter is removed at 24 hours status post insertion, the procedure will counted as a failed induction of labor with the Foley catheter and other methods of induction will be continued (i.e. Misoprostol, Artificial rupture or membranes, Oxytocin, etc.).

The time will begin at the start of the vaginal examination for placement of the Foley catheter and end after the balloon has been filled completely with saline.

Timeframe: Participants will be enrolled from April 2013 to January 2014 or until we have successfully enrolled 128 (64 per group) participants in the study. Data will be collected throughout the duration of the study to allow for all information from the hospital stay to be entered in the patient's medical record. Data analysis will occur from January 2014 to February 2014. Data presentation could occur up to 2 years after the complete of the study.

Data Collection:

The following variables will be recorded: Age; Race (0=NA; 1=Caucasian; 2=African American/Black; 3=Hispanic; 4=Asian 5=Other); BMI; Gravidity and Parity; Gestational Age; Reason for Indication for Induction (0=NA; 1=Post-term pregnancy; 2=Spontaneous Rupture of the Membranes; 3=Maternal disease; 4=Fetal indications; 5=Psychosocial parameters; 6= In vitro fertilization; 7=Advanced maternal age; 8 Maternal Request; 9=Other); History of Previous Cesarean Deliveries; Diabetes mellitus (0=NA; 1=Type I; 2=Type II; 3=Prediabetes; 4=GDM); Hypertensive disorders (0=NA; 1=Chronic HTN; 2= Gestational HTN; 3=Mild Preeclampsia; 4=Severe Preeclampsia; 5=Eclampsia); Renal Disease (0=No; 1=Yes); Other Comorbidities (0=No; 1=Yes); Documented Chorioamnionitis (0=No; 1=Yes); Epidural (0=No; 1=Yes); Inadvertent Rupture of Membranes (0=No; 1=Yes); Type of Delivery; Pain Assessment (0-10); Patient Satisfaction; Type of Delivery.

Points of time recorded will be: Time of insertion (Placement of Foley catheter); Time of expulsion of catheter; Time taken to place catheter; Time oxytocin started; Time oxytocin ended; Duration of treatment (Insertion to expulsion); Duration of induction (induction to delivery); Duration of oxytocin.

All variables will be recorded on an Excel spreadsheet by the resident physician or study coordinator. See attached example.

Eligibility criteria: Inclusion Criteria:

* Singleton fetus
* Cephalic presentation
* Indicated or Post-Estimated Date of Confinement
* Induction of labor with a Bishop score \< 5

Exclusion Criteria:

* Low lying placenta
* Undiagnosed vaginal bleeding
* History of induction or pre-induction agent during the same pregnancy
* Signs or symptoms of infection (i.e. Maternal fever)
* Rupture of membranes
* Multiple gestation
* Women with an urgent or emergent clinical situation in which the medical staff caring for the patient determines that obtaining consent would interfere with the patient's clinical care

Primary outcomes:
measure: Duration of Insertion Between Foley Catheter Groups With and Without a Stylette.
timeFrame: Followed throughout patient's hospital stay, approximately 10 days
Secondary outcomes:
measure: Pain Assessed by Visual Analog Scale (VAS)
timeFrame: Followed throughout patient's hospital stay, approximately 10 days
Other outcomes:
measure: Failure Rates of the Placement of a Foley Catheter
timeFrame: Followed throughout patient's hospital stay, approximately 10 days
Locations:
city: Milwaukee
country: United States
facility: Aurora Sinia Medical Center
state: Wisconsin
Study officials:
affiliation: Wake Forest University Health Sciences
name: Danish S Siddiqui, MD
role: PRINCIPAL_INVESTIGATOR
References: